These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5785067)

  • 1. Antimitotic activity of the methylhydrazine derivative Natulan in the ehrlich ascites carcinoma; dose-effect relationship.
    Llombart A; Mínguez FP
    Oncology; 1969; 23(3):201-8. PubMed ID: 5785067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytotoxic effect by a methylhydrazine compound].
    Zangger J
    Arzneimittelforschung; 1967 Apr; 17(4):511-3. PubMed ID: 5632453
    [No Abstract]   [Full Text] [Related]  

  • 3. Some histochemical alterations induced by the methylhydrazine derivative Natulan on two experimental ascites tumors.
    Llombart A; Peydro A; Llopis F
    Oncology; 1970; 24(5):358-69. PubMed ID: 4321140
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on the antimitotic effect of treatment with combined pancreatic desoxyribonuclease and p-(N'-methylhydrazino-methyl)-N-iso-propyl-benzamide hydrochloride on the cells of Ehrlich's ascites tumor].
    Magliulo E; Petrocini S; Fossati GC; Gorini S
    Arch Sci Med (Torino); 1968 May; 125(5):179-84. PubMed ID: 5696482
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental studies with methylhydrazine derivatives.
    Bollag W
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):158-70. PubMed ID: 5659723
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between the carcinostatic effects of x-rays and ibenzmethyzin on Ehrlich ascites carcinoma in mice.
    Rao KR
    Strahlentherapie; 1967 Dec; 134(4):574-84. PubMed ID: 5585415
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the extensively selective in-vivo destruction of subcutaneously implanted Ehrlich ascites tumor cells using 4-hydroxy-enales, especially 4-hydroxy-pentenal].
    Schauenstein E; Wünschmann B; Esterbauer H
    Z Krebsforsch; 1968; 71(1):21-9. PubMed ID: 4174631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental and clinical data on the antitumor action of hydrazine sulfate].
    Seĭts IF; Gershanovich ML; Filov VA; Danova LA; Kondrat'ev VB
    Vopr Onkol; 1975; 21(1):45-52. PubMed ID: 1090085
    [No Abstract]   [Full Text] [Related]  

  • 9. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of toluidine blue (TB) on the evolution of mouse Ehrlich ascites carcinoma.
    Samuel I; Popa L
    Rev Roum Virol (1972); 1973; 10(1):59-65. PubMed ID: 4709855
    [No Abstract]   [Full Text] [Related]  

  • 11. [Utilization of the immunodepressive action of antimitotic products for the study of their mechanism of action. Application to methylhydrazine].
    Kayibanda B; Amiel JL; Bérardet M
    C R Acad Hebd Seances Acad Sci D; 1968 Sep; 267(10):977-80. PubMed ID: 4973091
    [No Abstract]   [Full Text] [Related]  

  • 12. [The inhibition of nucleic acid synthesis and transplantibility of Ehrlich ascites tumor cells by natulan, trenimon and p-benzoquinone].
    Hölzel F; Wulfmeyer E; Schwencke I; Maass H
    Z Krebsforsch; 1967; 70(2):95-108. PubMed ID: 4232918
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the pharmacological characterization of a permanent in vitro growing strain of Ehrlich ascites tumor cells].
    Schmid I; Karzel K
    Arzneimittelforschung; 1968 Dec; 18(12):1498-500. PubMed ID: 4976453
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of various new cytostatic agents on DNA reduplication and proliferation kinetics in the Ehrlich-Lettre ascites tumor model].
    Andreeff M
    Verh Dtsch Ges Inn Med; 1974; 80():1678-80. PubMed ID: 4454511
    [No Abstract]   [Full Text] [Related]  

  • 16. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune.
    Komatsu N; Okubo S; Kikumoto S; Kimura K; Saito G
    Gan; 1969 Apr; 60(2):137-44. PubMed ID: 5810959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the mechanism of cytostatic action of methylhydrazine, II].
    Weitzel G; Schneider F; Fretzdorff AM; Durst J; Hirschmann WD
    Hoppe Seylers Z Physiol Chem; 1967 Apr; 348(4):433-42. PubMed ID: 5587962
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
    Ghosh M; Dutta S; Sanyal U
    Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of i.p. dopamine in mice bearing Ehrlich ascites carcinoma.
    Dasgupta PS; Lahiri T
    J Cancer Res Clin Oncol; 1987; 113(4):363-8. PubMed ID: 3597522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the mechanism of cytostatic action of methylhydrazine, 3].
    Weitzel G; Schneider F; Hirschmann WD; Durst J; Thauer R; Ochs H; Kummer D
    Hoppe Seylers Z Physiol Chem; 1967 Apr; 348(4):443-54. PubMed ID: 4385189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.